The anticipated film has already amassed a dedicated fandom and achieved a kind of cult status even before its release ...

Fancy a pizza with a view?The Vatican is marking the 400th anniversary of the consecration of St. Peter’s Basilica with a host of ...

Observant Muslims the world over will soon be united in a ritual of daily fasting from dawn to sunset as the Islamic holy ...

Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash. Eli Lilly on Monday said Orna, which is dedicated to engineering immune ...

Eli Lilly and Company (NYSE:LLY) is one of the best long term low volatility stocks to invest in. Eli Lilly and Company (NYSE:LLY) announced on January 30 significant plans to invest over $3.5 billion ...

Eli Lilly and Co. on Friday announced plans to spend more than $3.5 billion on a new injectable medicine and device manufacturing plant in Fogelsville, Pennsylvania, that will produce the company’s ...

Evangeline Lily gave an update on her treatment plan after suffering a traumatic brain injury. The “Lost” star, 46, took to Instagram on Sunday, sharing how she was “restor[ing her] brain health.” “I ...

Eli Lilly and Company remains a Buy, supported by robust incretin-driven growth and strategic expansion in obesity treatments. LLY pivots from scarcity to access economics, prioritizing volume over ...

These two healthcare stocks are top names to invest in, but they haven't both been doing well of late. Eli Lilly has generated $25 billion in revenue from its fast-growing GLP-1 drugs this year. Novo ...

Eli Lilly has halted development of a phase 2 P2X7 inhibitor for pain, the company confirmed to Fierce Biotech, in the latest shakeup to a pipeline that has already seen significant pivots this year.

Oct 23 (Reuters) - Eli Lilly (LLY.N), opens new tab signed an agreement with Cipla (CIPL.NS), opens new tab, allowing the Indian drugmaker to sell its blockbuster weight-loss drug under a separate ...